Want to join the conversation?
$AMGN will present new interim data from phase 2 trial provides further insight into Imlygic as potential combination partner with checkpoint inhibitor for patients with advanced melanoma skin cancer. Also, retrospective analyses of Vectibix combination regimen in metastatic colorectal cancer evaluate impact of tumor site of origin on efficacy.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!